Identification of promiscuous KIF20A long peptides bearing both CD4+ and CD8+ T-cell epitopes: KIF20A-specific CD4+ T-cell immunity in patients with malignant tumor. 2013

Yusuke Tomita, and Akira Yuno, and Hirotake Tsukamoto, and Satoru Senju, and Yasuhiro Kuroda, and Masatoshi Hirayama, and Atsushi Irie, and Kenta Kawahara, and Junji Yatsuda, and Akinobu Hamada, and Hirofumi Jono, and Koji Yoshida, and Takuya Tsunoda, and Hirotsugu Kohrogi, and Yoshihiro Yoshitake, and Yusuke Nakamura, and Masanori Shinohara, and Yasuharu Nishimura
Department of Immunogenetics, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.

OBJECTIVE To identify long peptides (LP) derived from a novel tumor-associated antigen (TAA), kinesin family member 20A (KIF20A), which induce tumor-specific T-helper type 1 (TH1) cells and CTLs. METHODS We combined information from a recently developed computer algorithm predicting HLA class II-binding peptides with KIF20A-derived CTL-epitope sequences presented by HLA-A2 (A*02:01) or HLA-A24 (A*24:02) to select candidate promiscuous TH1-cell epitopes containing CTL epitopes. Peripheral blood mononuclear cells (PBMC) derived from healthy donors or patients with head-and-neck malignant tumor (HNMT) were used to study the immunogenicity of KIF20A-LPs, and the in vitro cross-priming potential of KIF20A-LPs bearing CTL epitopes. We used HLA-A24 transgenic mice to address whether vaccination with KIF20A-LP induces efficient cross-priming of CTLs in vivo. The TH1-cell response to KIF20A-LPs in HNMT patients receiving immunotherapy with TAA-derived CTL-epitope peptides was analyzed using IFN-γ enzyme-linked immunospot assays. RESULTS We identified promiscuous KIF20A-LPs bearing naturally processed epitopes recognized by CD4(+) T cells and CTLs. KIF20A-specific CTLs were induced by vaccination with a KIF20A-LP in vivo. KIF20A expression was detected in 55% of HNMT by immunohistochemistry, and significant frequencies of KIF20A-specific TH1 cell responses were detected after short-term in vitro stimulation of PBMCs with KIF20A-LPs in 50% of HNMT patients, but not in healthy donors. Furthermore, these responses were associated with KIF20A expression in HNMT tissues. CONCLUSIONS These are the first results showing the presence of KIF20A-specific TH1 cell responses in HNMT patients and underline the possible utility of KIF20A-LPs for propagation of TH1 cells and CTLs.

UI MeSH Term Description Entries
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003713 Dendritic Cells Specialized cells of the hematopoietic system that have branch-like extensions. They are found throughout the lymphatic system, and in non-lymphoid tissues such as SKIN and the epithelia of the intestinal, respiratory, and reproductive tracts. They trap and process ANTIGENS, and present them to T-CELLS, thereby stimulating CELL-MEDIATED IMMUNITY. They are different from the non-hematopoietic FOLLICULAR DENDRITIC CELLS, which have a similar morphology and immune system function, but with respect to humoral immunity (ANTIBODY PRODUCTION). Dendritic Cells, Interdigitating,Interdigitating Cells,Plasmacytoid Dendritic Cells,Veiled Cells,Dendritic Cells, Interstitial,Dendritic Cells, Plasmacytoid,Interdigitating Dendritic Cells,Interstitial Dendritic Cells,Cell, Dendritic,Cell, Interdigitating,Cell, Interdigitating Dendritic,Cell, Interstitial Dendritic,Cell, Plasmacytoid Dendritic,Cell, Veiled,Cells, Dendritic,Cells, Interdigitating,Cells, Interdigitating Dendritic,Cells, Interstitial Dendritic,Cells, Plasmacytoid Dendritic,Cells, Veiled,Dendritic Cell,Dendritic Cell, Interdigitating,Dendritic Cell, Interstitial,Dendritic Cell, Plasmacytoid,Interdigitating Cell,Interdigitating Dendritic Cell,Interstitial Dendritic Cell,Plasmacytoid Dendritic Cell,Veiled Cell
D005260 Female Females
D006258 Head and Neck Neoplasms Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651) Cancer of Head and Neck,Head Cancer,Head Neoplasm,Head and Neck Cancer,Head and Neck Neoplasm,Neck Cancer,Neck Neoplasm,Neck Neoplasms,Neoplasms, Upper Aerodigestive Tract,UADT Neoplasm,Upper Aerodigestive Tract Neoplasm,Upper Aerodigestive Tract Neoplasms,Cancer of Head,Cancer of Neck,Cancer of the Head,Cancer of the Head and Neck,Cancer of the Neck,Head Neoplasms,Head, Neck Neoplasms,Neoplasms, Head,Neoplasms, Head and Neck,Neoplasms, Neck,UADT Neoplasms,Cancer, Head,Cancer, Neck,Cancers, Head,Cancers, Neck,Head Cancers,Neck Cancers,Neoplasm, Head,Neoplasm, Neck,Neoplasm, UADT,Neoplasms, UADT

Related Publications

Yusuke Tomita, and Akira Yuno, and Hirotake Tsukamoto, and Satoru Senju, and Yasuhiro Kuroda, and Masatoshi Hirayama, and Atsushi Irie, and Kenta Kawahara, and Junji Yatsuda, and Akinobu Hamada, and Hirofumi Jono, and Koji Yoshida, and Takuya Tsunoda, and Hirotsugu Kohrogi, and Yoshihiro Yoshitake, and Yusuke Nakamura, and Masanori Shinohara, and Yasuharu Nishimura
January 2008, Journal of virology,
Yusuke Tomita, and Akira Yuno, and Hirotake Tsukamoto, and Satoru Senju, and Yasuhiro Kuroda, and Masatoshi Hirayama, and Atsushi Irie, and Kenta Kawahara, and Junji Yatsuda, and Akinobu Hamada, and Hirofumi Jono, and Koji Yoshida, and Takuya Tsunoda, and Hirotsugu Kohrogi, and Yoshihiro Yoshitake, and Yusuke Nakamura, and Masanori Shinohara, and Yasuharu Nishimura
January 2011, Journal of biomedicine & biotechnology,
Yusuke Tomita, and Akira Yuno, and Hirotake Tsukamoto, and Satoru Senju, and Yasuhiro Kuroda, and Masatoshi Hirayama, and Atsushi Irie, and Kenta Kawahara, and Junji Yatsuda, and Akinobu Hamada, and Hirofumi Jono, and Koji Yoshida, and Takuya Tsunoda, and Hirotsugu Kohrogi, and Yoshihiro Yoshitake, and Yusuke Nakamura, and Masanori Shinohara, and Yasuharu Nishimura
February 1996, European journal of immunology,
Yusuke Tomita, and Akira Yuno, and Hirotake Tsukamoto, and Satoru Senju, and Yasuhiro Kuroda, and Masatoshi Hirayama, and Atsushi Irie, and Kenta Kawahara, and Junji Yatsuda, and Akinobu Hamada, and Hirofumi Jono, and Koji Yoshida, and Takuya Tsunoda, and Hirotsugu Kohrogi, and Yoshihiro Yoshitake, and Yusuke Nakamura, and Masanori Shinohara, and Yasuharu Nishimura
January 2008, Clinical cancer research : an official journal of the American Association for Cancer Research,
Yusuke Tomita, and Akira Yuno, and Hirotake Tsukamoto, and Satoru Senju, and Yasuhiro Kuroda, and Masatoshi Hirayama, and Atsushi Irie, and Kenta Kawahara, and Junji Yatsuda, and Akinobu Hamada, and Hirofumi Jono, and Koji Yoshida, and Takuya Tsunoda, and Hirotsugu Kohrogi, and Yoshihiro Yoshitake, and Yusuke Nakamura, and Masanori Shinohara, and Yasuharu Nishimura
May 2012, Clinical cancer research : an official journal of the American Association for Cancer Research,
Yusuke Tomita, and Akira Yuno, and Hirotake Tsukamoto, and Satoru Senju, and Yasuhiro Kuroda, and Masatoshi Hirayama, and Atsushi Irie, and Kenta Kawahara, and Junji Yatsuda, and Akinobu Hamada, and Hirofumi Jono, and Koji Yoshida, and Takuya Tsunoda, and Hirotsugu Kohrogi, and Yoshihiro Yoshitake, and Yusuke Nakamura, and Masanori Shinohara, and Yasuharu Nishimura
December 2005, Molecular therapy : the journal of the American Society of Gene Therapy,
Yusuke Tomita, and Akira Yuno, and Hirotake Tsukamoto, and Satoru Senju, and Yasuhiro Kuroda, and Masatoshi Hirayama, and Atsushi Irie, and Kenta Kawahara, and Junji Yatsuda, and Akinobu Hamada, and Hirofumi Jono, and Koji Yoshida, and Takuya Tsunoda, and Hirotsugu Kohrogi, and Yoshihiro Yoshitake, and Yusuke Nakamura, and Masanori Shinohara, and Yasuharu Nishimura
September 2021, Cells,
Yusuke Tomita, and Akira Yuno, and Hirotake Tsukamoto, and Satoru Senju, and Yasuhiro Kuroda, and Masatoshi Hirayama, and Atsushi Irie, and Kenta Kawahara, and Junji Yatsuda, and Akinobu Hamada, and Hirofumi Jono, and Koji Yoshida, and Takuya Tsunoda, and Hirotsugu Kohrogi, and Yoshihiro Yoshitake, and Yusuke Nakamura, and Masanori Shinohara, and Yasuharu Nishimura
July 1993, Immunobiology,
Yusuke Tomita, and Akira Yuno, and Hirotake Tsukamoto, and Satoru Senju, and Yasuhiro Kuroda, and Masatoshi Hirayama, and Atsushi Irie, and Kenta Kawahara, and Junji Yatsuda, and Akinobu Hamada, and Hirofumi Jono, and Koji Yoshida, and Takuya Tsunoda, and Hirotsugu Kohrogi, and Yoshihiro Yoshitake, and Yusuke Nakamura, and Masanori Shinohara, and Yasuharu Nishimura
March 2002, Infection and immunity,
Yusuke Tomita, and Akira Yuno, and Hirotake Tsukamoto, and Satoru Senju, and Yasuhiro Kuroda, and Masatoshi Hirayama, and Atsushi Irie, and Kenta Kawahara, and Junji Yatsuda, and Akinobu Hamada, and Hirofumi Jono, and Koji Yoshida, and Takuya Tsunoda, and Hirotsugu Kohrogi, and Yoshihiro Yoshitake, and Yusuke Nakamura, and Masanori Shinohara, and Yasuharu Nishimura
December 2013, Human immunology,
Copied contents to your clipboard!